Filing Details
- Accession Number:
- 0001567619-21-008650
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-04-27 18:23:07
- Reporting Period:
- 2021-04-23
- Accepted Time:
- 2021-04-27 18:23:07
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1370053 | Anaptysbio Inc | ANAB | Pharmaceutical Preparations (2834) | 203828755 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1454385 | Oleg Nodelman | 357 Tehama Street #3 San Francisco CA 94103 | Yes | No | Yes | No | |
| 1587114 | Ecor1 Capital, Llc | 357 Tehama Street #3 San Francisco CA 94103 | Yes | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-04-23 | 99,600 | $23.54 | 7,251,224 | No | 4 | P | Indirect | See Note 1 |
| Common Stock | Acquisiton | 2021-04-26 | 13,900 | $23.80 | 7,265,124 | No | 4 | P | Indirect | See Note 1 |
| Common Stock | Acquisiton | 2021-04-27 | 33,800 | $23.82 | 7,298,924 | No | 4 | P | Indirect | See Note 1 |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Indirect | See Note 1 |
| No | 4 | P | Indirect | See Note 1 |
| No | 4 | P | Indirect | See Note 1 |
Footnotes
- The filing persons (the "Filers") are EcoR1 Capital, LLC ("EcoR1"), Oleg Nodelman and EcoR1 Capital Fund Qualified, L.P. ("Qualified Fund"). EcoR1 is the investment adviser and general partner of private funds, including Qualified Fund (collectively, the "Funds"). Mr. Nodelman is the manager and controlling owner of EcoR1 and a director of the Issuer. EcoR1 is filing this Form 4 for itself, Mr. Nodelman and Qualified Fund. The Filers are filing this Form 4 jointly, but not as a group, and each expressly disclaims membership in a group within the meaning of Rule 13d-5(b) under the Securities Exchange Act of 1934, as amended. The Funds hold these securities directly for the benefit of their investors. EcoR1 indirectly beneficially owns them as the investment adviser to the Funds, and Mr. Nodelman indirectly beneficially owns them as the control person of EcoR1. The Filers disclaim beneficial ownership of such securities except to the extent of their pecuniary interest therein.
- Qualified Fund purchased all of the securities described in this transaction.
Billionaire Hedge Funds
